Welcome to our dedicated page for Lifecore Biomedical SEC filings (Ticker: LFCR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lifecore Biomedical, Inc. filings document the reporting obligations of a Nasdaq-listed injectables CDMO that develops, fills and finishes sterile pharmaceutical products and manufactures injectable-grade hyaluronic acid. Its 8-K reports furnish operating results, financial-condition updates and Regulation FD investor presentation materials tied to the company’s CDMO programs and corporate updates.
Proxy and governance filings cover director elections, annual meeting voting, executive compensation, incentive plan matters, shareholder proposal procedures and the company’s fiscal-year change to calendar-year reporting. The filings also reference the company’s common stock and Series A Convertible Preferred Stock within voting and capital-structure disclosures.